Skip to main content
logo
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China flag China · Delayed Price · Currency is CNY
28.82
-0.06 (-0.21%)
Nov 14, 2025, 3:00 PM CST

SHA:600196 Revenue

Shanghai Fosun Pharmaceutical (Group) had revenue of 9.88B CNY in the quarter ending September 30, 2025, a decrease of -5.46%. This brings the company's revenue in the last twelve months to 39.55B, down -4.96% year-over-year. In the year 2024, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.07B, down -0.80%.

Revenue (ttm)
39.55B
Revenue Growth
-4.96%
P/S Ratio
1.82
Revenue / Employee
975.14K
Employees
40,557
Market Cap
71.92B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202441.07B-332.34M-0.80%
Dec 31, 202341.40B-2.55B-5.81%
Dec 31, 202243.95B4.94B12.66%
Dec 31, 202139.01B8.70B28.72%
Dec 31, 202030.31B1.72B6.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
WuXi AppTec43.88B
Huadong Medicine43.09B
Yunnan Baiyao Group Co.,Ltd40.77B
Shenzhen Mindray Bio-Medical Electronics33.07B
Jiangsu Hengrui Medicine30.98B
Zhejiang NHU Company22.47B
Aier Eye Hospital Group22.17B
Shanghai United Imaging Healthcare12.20B
Revenue Rankings

Shanghai Fosun Pharmaceutical (Group) News

More News